171 related articles for article (PubMed ID: 23611268)
1. [Screening of differentially expressed microRNAs in borderline and malignant gastrointestinal stromal tumors].
Shi Y; Wang CZ; Hou YY; He DM; Xu C; Liu YL; Hu Q; Akesu S; Zeng HY; Shen KT; Tan YS; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):20-5. PubMed ID: 23611268
[TBL] [Abstract][Full Text] [Related]
2. Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray.
Tong HX; Zhou YH; Hou YY; Zhang Y; Huang Y; Xie B; Wang JY; Jiang Q; He JY; Shao YB; Han WM; Tan RY; Zhu J; Lu WQ
World J Gastroenterol; 2015 May; 21(19):5843-55. PubMed ID: 26019448
[TBL] [Abstract][Full Text] [Related]
3. Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.
Haller F; von Heydebreck A; Zhang JD; Gunawan B; Langer C; Ramadori G; Wiemann S; Sahin O
J Pathol; 2010 Jan; 220(1):71-86. PubMed ID: 19768731
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
[TBL] [Abstract][Full Text] [Related]
5. Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
Yun S; Kim WK; Kwon Y; Jang M; Bauer S; Kim H
Int J Cancer; 2018 May; 142(10):2080-2093. PubMed ID: 29277888
[TBL] [Abstract][Full Text] [Related]
6. PIK3C2A is a gene-specific target of microRNA-518a-5p in imatinib mesylate-resistant gastrointestinal stromal tumor.
Shi Y; Gao X; Hu Q; Li X; Xu J; Lu S; Liu Y; Xu C; Jiang D; Lin J; Xue A; Tan Y; Shen K; Hou Y
Lab Invest; 2016 Jun; 96(6):652-60. PubMed ID: 26950487
[TBL] [Abstract][Full Text] [Related]
7. A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors.
Isosaka M; Niinuma T; Nojima M; Kai M; Yamamoto E; Maruyama R; Nobuoka T; Nishida T; Kanda T; Taguchi T; Hasegawa T; Tokino T; Hirata K; Suzuki H; Shinomura Y
PLoS One; 2015; 10(7):e0133754. PubMed ID: 26214687
[TBL] [Abstract][Full Text] [Related]
8. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
[TBL] [Abstract][Full Text] [Related]
9. Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromal tumor.
Yamamoto H; Kohashi K; Fujita A; Oda Y
Mod Pathol; 2013 Apr; 26(4):563-71. PubMed ID: 23196799
[TBL] [Abstract][Full Text] [Related]
10. MiR-320a downregulation is associated with imatinib resistance in gastrointestinal stromal tumors.
Gao X; Shen K; Wang C; Ling J; Wang H; Fang Y; Shi Y; Hou Y; Qin J; Sun Y; Qin X
Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):72-5. PubMed ID: 24217767
[TBL] [Abstract][Full Text] [Related]
11. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
Koelz M; Lense J; Wrba F; Scheffler M; Dienes HP; Odenthal M
Int J Oncol; 2011 Feb; 38(2):503-11. PubMed ID: 21132270
[TBL] [Abstract][Full Text] [Related]
13. Expression of microRNAs in basal cell carcinoma.
Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
[TBL] [Abstract][Full Text] [Related]
14. Microarray analysis of differentially expressed microRNAs in allergic rhinitis.
Shaoqing Y; Ruxin Z; Guojun L; Zhiqiang Y; Hua H; Shudong Y; Jie Z
Am J Rhinol Allergy; 2011; 25(6):e242-6. PubMed ID: 22185732
[TBL] [Abstract][Full Text] [Related]
15. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
16. Altered microRNA expression profile with miR-27b down-regulation correlated with disease activity of oral lichen planus.
Zhang WY; Liu W; Zhou YM; Shen XM; Wang YF; Tang GY
Oral Dis; 2012 Apr; 18(3):265-70. PubMed ID: 22077423
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
19. miR-182 controls cell growth in gastrointestinal stromal tumors by negatively regulating CYLD expression.
Ling T; Yu F; Cao H
Oncol Rep; 2018 Dec; 40(6):3705-3713. PubMed ID: 30542706
[TBL] [Abstract][Full Text] [Related]
20. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]